AI assistant
IRADIMED CORP — Director's Dealing 2022
Dec 8, 2022
32324_dirs_2022-12-08_b4cb9191-d442-4590-9fa2-a7bb443e140f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-12-06
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-06 | Common Stock | A | 5000 | $28.5455 | Acquired | 26490 | Direct |
| 2022-12-07 | Common Stock | A | 5000 | $28.5811 | Acquired | 31490 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $28.45 to $28.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $28.48 to $28.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.